{"id":"https://openalex.org/W4408621184","doi":"https://doi.org/10.1038/s41467-025-57496-0","title":"Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","display_name":"Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","publication_year":2025,"publication_date":"2025-03-19","ids":{"openalex":"https://openalex.org/W4408621184","doi":"https://doi.org/10.1038/s41467-025-57496-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/40108132","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11923157"},"language":"en","primary_location":{"id":"doi:10.1038/s41467-025-57496-0","doi":"https://doi.org/10.1038/s41467-025-57496-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-025-57496-0","pdf_url":null,"source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"volume":null,"type":"erratum","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1038/s41467-025-57496-0","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085293018","display_name":"Stefano Pierini","orcid":"https://orcid.org/0000-0003-3082-1291","observed_orcids":["https://orcid.org/0000-0003-3082-1291"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefano Pierini","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3082-1291","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075450571","display_name":"Rashid T. Gabbasov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashid Gabbasov","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079749739","display_name":"Maria Cec\u00edlia Oliveira-Nunes","orcid":"https://orcid.org/0000-0002-4630-3918","observed_orcids":["https://orcid.org/0000-0002-4630-3918"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Cecilia Oliveira-Nunes","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0002-4630-3918","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045758","display_name":"Rehman Qureshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rehman Qureshi","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050956498","display_name":"Alison M. Worth","orcid":"https://orcid.org/0009-0008-8769-1129","observed_orcids":["https://orcid.org/0009-0008-8769-1129"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison Worth","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0009-0008-8769-1129","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101575275","display_name":"Shuo Huang","orcid":"https://orcid.org/0000-0002-9116-1242","observed_orcids":["https://orcid.org/0000-0002-9116-1242"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuo Huang","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020904079","display_name":"Karan K. Nagar","orcid":"https://orcid.org/0000-0002-6965-4825","observed_orcids":["https://orcid.org/0000-0002-6965-4825"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karan Nagar","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006310456","display_name":"Crystal Griffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal Griffin","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005687426","display_name":"Lurong Lian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lurong Lian","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077778242","display_name":"Yumi Yashiro\u2013Ohtani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yumi Yashiro-Ohtani","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024130944","display_name":"Kayleigh C. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kayleigh Ross","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036961290","display_name":"D. Christopher Sloas","orcid":"https://orcid.org/0000-0001-8091-3827","observed_orcids":["https://orcid.org/0000-0001-8091-3827"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Sloas","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071424437","display_name":"Michael S. Ball","orcid":"https://orcid.org/0000-0001-7322-7642","observed_orcids":["https://orcid.org/0000-0001-7322-7642"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Ball","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088338768","display_name":"Benjamin H. Schott","orcid":"https://orcid.org/0000-0003-4553-4068","observed_orcids":["https://orcid.org/0000-0003-4553-4068"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Schott","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0003-4553-4068","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069385878","display_name":"Poonam Sonawane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Poonam Sonawane","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Linara Cornell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linara Cornell","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001045238","display_name":"Daniel Blumenthal","orcid":"https://orcid.org/0000-0002-9207-5848","observed_orcids":["https://orcid.org/0000-0002-9207-5848"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Blumenthal","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080463199","display_name":"Sotheavy Chhum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sotheavy Chhum","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048697540","display_name":"Nicholas G. Minutolo","orcid":"https://orcid.org/0000-0002-3612-0958","observed_orcids":["https://orcid.org/0000-0002-3612-0958"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Minutolo","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084467634","display_name":"Kerri Ciccaglione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerri Ciccaglione","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074094957","display_name":"Lauren C. Shaw","orcid":"https://orcid.org/0000-0002-4104-2261","observed_orcids":["https://orcid.org/0000-0002-4104-2261"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Shaw","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070830007","display_name":"Isaac Zentner","orcid":"https://orcid.org/0000-0001-9828-271X","observed_orcids":["https://orcid.org/0000-0001-9828-271X"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isaac Zentner","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102748347","display_name":"Hyam I. Levitsky","orcid":"https://orcid.org/0000-0002-6080-3871","observed_orcids":["https://orcid.org/0000-0002-6080-3871","https://orcid.org/0000-0002-9540-1442"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyam Levitsky","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058378222","display_name":"Olga E. Shestova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Shestova","raw_affiliation_strings":["Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039491957","display_name":"Saar I. Gill","orcid":"https://orcid.org/0000-0001-7946-7778","observed_orcids":["https://orcid.org/0000-0001-7946-7778"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saar Gill","raw_affiliation_strings":["Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0001-7946-7778","affiliations":[{"raw_affiliation_string":"Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035194305","display_name":"Bindu Varghese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bindu Varghese","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117306146","display_name":"Daniel J. Cushing","orcid":"https://orcid.org/0000-0003-3577-4690","observed_orcids":["https://orcid.org/0000-0003-3577-4690"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Cushing","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030276158","display_name":"Sabrina Ceeraz DeLong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrina Ceeraz DeLong","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070066005","display_name":"Sascha D. Abramson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sascha Abramson","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078225939","display_name":"Thomas Condamine","orcid":"https://orcid.org/0000-0001-9450-2762","observed_orcids":["https://orcid.org/0000-0001-9450-2762"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Condamine","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0001-9450-2762","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011966705","display_name":"Michael Klichinsky","orcid":"https://orcid.org/0000-0001-8935-163X","observed_orcids":["https://orcid.org/0000-0001-8935-163X"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Klichinsky","raw_affiliation_strings":["Carisma Therapeutics Inc, Philadelphia, PA, USA. michael.klichinsky@carismatx.com","Carisma Therapeutics Inc, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0001-8935-163X","affiliations":[{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA. michael.klichinsky@carismatx.com","institution_ids":["https://openalex.org/I4210155370"]},{"raw_affiliation_string":"Carisma Therapeutics Inc, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210155370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011966705"],"corresponding_institution_ids":["https://openalex.org/I4210155370"],"apc_list":{"value":6990,"currency":"USD","value_usd":6990},"apc_paid":{"value":6990,"currency":"USD","value_usd":6990},"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"1","first_page":"2692","last_page":"2692"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.399399995803833,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-macrophages","display_name":"chimeric antigen receptor macrophages","score":0.9940000176429749},{"id":"https://openalex.org/keywords/her2-positive-solid-tumors","display_name":"HER2-positive solid tumors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6880000233650208},{"id":"https://openalex.org/keywords/granzyme-b","display_name":"granzyme B","score":0.7419999837875366},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.7649999856948853},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.8605034947395325},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6297703981399536},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5193970799446106},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.43884342908859253},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41727888584136963},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4118783175945282},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33943772315979004},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2282816767692566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1941700279712677},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1501024067401886}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1038/s41467-025-57496-0","doi":"https://doi.org/10.1038/s41467-025-57496-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-025-57496-0","pdf_url":null,"source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11923157","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11923157","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Commun","raw_type":"Text"},{"id":"pmid:40108132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40108132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature communications","raw_type":"Published Erratum"},{"id":"pmh:oai:RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-57496-0","doi":null,"is_oa":false,"landing_page_url":"https://www.nature.com/articles/s41467-025-57496-0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:5419673c75914aed9ecb23e194e7cab2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5419673c75914aed9ecb23e194e7cab2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, Vol 16, Iss 1, Pp 1-2 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41467-025-57496-0","doi":"https://doi.org/10.1038/s41467-025-57496-0","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-025-57496-0","pdf_url":null,"source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4406420802","https://openalex.org/W4282971272","https://openalex.org/W3213920816","https://openalex.org/W6980549718","https://openalex.org/W4308377076","https://openalex.org/W6977278141","https://openalex.org/W3113041386","https://openalex.org/W4365512283","https://openalex.org/W4234191926","https://openalex.org/W4308385784"],"abstract_inverted_index":{"In":[0,69],"the":[1,4,16,22,45,57,70,87,93],"version":[2],"of":[3,92],"article":[5],"initially":[6],"published,":[7],"there":[8],"was":[9,19,52,65,76],"an":[10],"error":[11],"in":[12,42,86],"Fig.":[13,43,72],"4b":[14],"where":[15],"wrong":[17],"value":[18],"shown":[20],"on":[21],"significance":[23],"bar":[24],"between":[25],"CAR-M":[26,28],"and":[27,35,63,89],"+":[29],"aPD1":[30],"(":[31],"p":[32,39],"<":[33,40],"0.05,":[34],"not,":[36],"as":[37],"current,":[38],"0.01);":[41],"4d,":[44],"top-right":[46],"immunofluorescence":[47],"image":[48,80],"currently":[49],"labelled":[50,54],"\u201caPD-1\u201d":[51],"originally":[53,67],"\u201cUTD-M,\u201d":[55],"while":[56],"color":[58],"key":[59],"for":[60,79],"granzyme":[61],"B":[62],"CD4":[64],"not":[66,77],"present.":[68],"Supplementary":[71],"1c":[73],"legend,":[74],"Biorender":[75],"credited":[78],"generation.":[81],"The":[82],"changes":[83],"are":[84],"reflected":[85],"HTML":[88],"PDF":[90],"versions":[91],"article.":[94]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-03-20T00:00:00"}